Results 291 to 300 of about 17,182,321 (391)

Small-cell carcinoma of the lung: A five-year experience with combined modality therapy [PDF]

, 1980
Philip C. Hoffman, Harvey M. Golomb, Jacob D. Bitran, Tom R. DeMeester, Lionel Cohen, Melvin L. Griem, Judith A. Cooksey, Uri Mintz, Leo I. Gordon, Richard K. Desser, Ann Kinnealey, Corinne A. Sovik   +11 more
openalex   +1 more source

Simultaneous inhibition of TRIM24 and TRIM28 sensitises prostate cancer cells to antiandrogen therapy, decreasing VEGF signalling and angiogenesis

Molecular Oncology, EarlyView.
TRIM24 and TRIM28 are androgen receptor (AR) coregulators which exhibit increased expression with cancer progression. Both TRIM24 and TRIM28 combine to influence the response of castrate‐resistant prostate cancer (CRPC) cells to AR inhibitors by mediating AR signalling, regulation of MYC and upregulating VEGF to promote angiogenesis. Castrate‐resistant
Damien A. Leach, Nilesh Chatterjee, Kellie Spahr, Gilberto Serrano de Almeida, Anabel Varela‐Carver, Taimur T. Shah, Mathias Winkler, Hashim U. Ahmed, Charlotte L. Bevan   +8 more
wiley   +1 more source

Investigating nanoparticle's utilization in stem cell therapy for neurological disorders. [PDF]

Am J Stem Cells
Aziz S, Anbreen S, Shahzad S, Ahmed MS, Sharma V, Yang J, Ali L.   +6 more
europepmc   +1 more source

A clinical trial of anti-idiotype therapy for B cell malignancy

, 1985
TC Meeker, James N. Lowder, DG Maloney, RA Miller, K Thielemans, R Warnke, Ronald Levy   +6 more
openalex   +1 more source

Toward Defining an Optimal Therapy for Hairy Cell Leukemia [PDF]

, 1989
Sandra J. Horning
openalex   +1 more source

Tumor clusters with divergent inflammation and human retroelement expression determine the clinical outcome of patients with serous ovarian cancer

Molecular Oncology, EarlyView.
Analysis of treatment‐naïve high‐grade serous ovarian carcinoma (HGSOC) and control tissues for ERVs, LINE‐1 (L1), inflammation, and immune checkpoints identified five clusters with diverse patient recurrence‐free survivals. An inflammation score was calculated and correlated with retroelement expression, where one novel cluster (Triple‐I) with high ...
Laura Glossner, Markus Eckstein, Christoph Mark, Matthias W. Beckmann, Arndt Hartmann, Pamela L. Strissel, Reiner Strick   +6 more
wiley   +1 more source

Chimeric antigen receptor (CAR) -T cell therapy treatment Richter's transformation. [PDF]

Front Oncol
Feng S, Zheng P, Liu H, Sun M, Guo Y, Ma L, Liu R, Fu Z, Yang F, Ke X, Hu K.   +10 more
europepmc   +1 more source

Bone marrow cell count per cubic millimeter bone marrow: a new parameter for quantitating therapy-induced cytoreduction in acute leukemia [PDF]

, 1982
W Hiddemann, BD Clarkson, T Buchner, MR Melamed, Michael Andreeff   +4 more
openalex   +1 more source

A DIA‐MS‐based proteomics approach to find potential serum prognostic biomarkers in glioblastoma patients

Molecular Oncology, EarlyView.
A DIA‐MS‐based proteomics analysis of serum samples from GB patients and healthy controls showed that high levels of IL1R2 and low levels of CRTAC1 and HRG in serum are associated with poor survival outcomes for GB patients. These circulating proteins could serve as biomarkers for the prediction of outcome in patients with GB.
Anne Clavreul, François Guillonneau, Odile Blanchet, Hamza Lasla, Audrey Rousseau, Catherine Guette, Alice Boissard, Cécile Henry, Morgan Dhondt, Pascal Jézéquel, Philippe Menei, Jean‐Michel Lemée   +11 more
wiley   +1 more source

CAR-T cell therapy for cancer: current challenges and future directions. [PDF]

Signal Transduct Target Ther
Zugasti I, Espinosa-Aroca L, Fidyt K, Mulens-Arias V, Diaz-Beya M, Juan M, Urbano-Ispizua Á, Esteve J, Velasco-Hernandez T, Menéndez P.   +9 more
europepmc   +1 more source